Sol-gel Technologies Ltd. income statement

In fiscal 2025, Sol-gel Technologies Ltd. reported revenue of $19.4m, up 68.0% on the year before, operating income of −$7.5m (a -38.9% margin) and net income of −$6.1m, or −$2.19 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Sol-gel Technologies Ltd.: income statement, annual
Fiscal year	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	0	0	23	9	31	4	2	12	19
Research and development	26	28	41	28	20	13	24	18	23
General and administrative	6	6	8	11	8	7	7	6	4
Operating income	−32	−34	−26	−30	3	−16	−29	−12	−8
Income before tax	−32	−32	−25	−29	3	—	—	—	—
Income tax	—	—	0	0	0	—	0	0	0
Net income	−32	−32	−25	−29	3	−15	−27	−11	−6
Diluted EPS	$16.73	$18.00	−$12.60	−$13.00	$1.40	−$6.50	−$10.01	−$3.79	−$2.19
Diluted shares (average)	2m	2m	2m	2m	2m	2m	3m	3m	3m
EBITDA	−31	−33	−25	−29	4	−16	−29	−12	−7

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: SLGL vs ZYBT JAGX vs SLGL SLGL vs VRCA

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Sol-gel Technologies Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Sol-gel Technologies Ltd.